Open Call to all ATMP developers

31 Mar 2017

ATMP developers – past and present – are invited to participate in a survey investigating these factors, impacting the development ATMPs within the EU. Amongst others, the following factors will be explored: scientific challenges, manufacturing issues, clinical considerations and regulatory requirements. The survey will be executed by the Escher platform of Lygature together with Utrecht University.

The survey will be conducted on-line and take approximately 30 minutes to complete. Data collection will start end of March and results are expected late 2017.

Interested ATMP developers can contact Lygature to participate:
In order to optimise the confidentiality of the participating developers Lygature will act as intermediate (as honest broker) between the ATMP developers and the Utrecht University research team. The name and contact details of the developer will be separated from the answers. Results will only be published using aggregate data, making it impossible to trace back information to individual developers. The intent is to publish the results in a scientific journal.

The research is carried out with an unrestricted research grant from European Federation of Pharmaceutical Industries and Associations (EFPIA) and European Biopharmaceutical Enterprises (EBE).

2017-09-14T12:28:53+00:00March 31, 2017|